Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-23-019259

Director acquired 2,534 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
STARR CHRISTOPHER M Director 2023-06-30 Option exercise +2,534 20,797 D
Derivatives
STARR CHRISTOPHER M Director 2023-06-30 Option exercise · Restricted Stock Units −2,534 5,066 D
Loading xslF345X04/rdgdoc.xml…